Literature DB >> 24423351

The typology of metabolic syndrome in the transition to adulthood.

Takara L Stanley1, Minghua L Chen, Elizabeth Goodman.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) is a clustering of risks associated with cardiometabolic disease in adults. Obesity is considered the major etiologic factor. However, unlike obesity, the natural history of MetS as adolescents transition to adulthood is unknown.
OBJECTIVE: The purpose of this study was to characterize the typology of MetS as adolescents transition to young adulthood and to explore determinants of that typology. DESIGN/PARTICIPANTS: A total of 458 participants from a school-based longitudinal cohort study of baseline 5th to 12th graders were followed for 9 years.
METHODS: Based on the presence or absence of MetS at study visits (year [Y] 1, Y4, Y8, and Y10), a MetS typology was defined, and its characteristics were explored using multinomial regression modeling.
RESULTS: Both obesity and MetS increased (obesity from 21.0% to 33.4% and MetS from 2.8% to 17.9%). MetS typology was as follows: never, 76.9%; incident, 16.4%; unstable/remitted, 5.7%; and persistent, 1.1%. Of Y1 MetS-positive cases, 61.5% remitted, as did 36.4% of Y4 MetS-positive cases and 25% of Y8 MetS-positive cases. Most incident cases (56.0%, n = 42) occurred in Y10; only 12% (n = 9) occurred in Y4. Obesity increased the odds of MetS (incident: odds ratio [OR] = 4.42, 95% confidence interval [CI] = 2.23-8.76; unstable/remitted: OR = 7.79, 95% CI = 3.12-19.41; persistent: OR = 31.36, 95% CI = 2.99-328.98). In addition, changes in body mass index over the study were associated with persistent (OR = 1.27, 95% CI = 1.03-1.56) and incident MetS (OR = 1.49, 95% CI = 1.31-1.71), but not unstable/remitted MetS (OR = 1.09, 95% CI = 0.99-1.19). Of note, body mass index increased for 77% of those with unstable/remitted MetS, including 90% (n = 9/10) of persistently obese youth with unstable/remitted MetS.
CONCLUSIONS: During the transition to adulthood, the diagnosis of MetS is highly unstable and fluctuates even among those who are obese and gaining weight.

Entities:  

Mesh:

Year:  2014        PMID: 24423351      PMCID: PMC3942239          DOI: 10.1210/jc.2013-3531

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

1.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  H C McGill; C A McMahan; A W Zieske; G D Sloop; J V Walcott; D A Troxclair; G T Malcom; R E Tracy; M C Oalmann; J P Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

Review 2.  Origin of atherosclerosis in childhood and adolescence.

Authors:  H C McGill; C A McMahan; E E Herderick; G T Malcom; R E Tracy; J P Strong
Journal:  Am J Clin Nutr       Date:  2000-11       Impact factor: 7.045

3.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

4.  Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study.

Authors:  Joey C Eisenmann; Gregory J Welk; Eric E Wickel; Steven N Blair
Journal:  Am J Hum Biol       Date:  2004 Nov-Dec       Impact factor: 1.937

5.  Five-year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health.

Authors:  Penny Gordon-Larsen; Linda S Adair; Melissa C Nelson; Barry M Popkin
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

6.  Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Authors:  Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

7.  Impact of objective and subjective social status on obesity in a biracial cohort of adolescents.

Authors:  Elizabeth Goodman; Nancy E Adler; Stephen R Daniels; John A Morrison; Gail B Slap; Lawrence M Dolan
Journal:  Obes Res       Date:  2003-08

8.  Cholesterol screening in childhood: does it predict adult hypercholesterolemia? The Beaver County experience.

Authors:  T J Orchard; R P Donahue; L H Kuller; P N Hodge; A L Drash
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

9.  Obesity and the metabolic syndrome in children and adolescents.

Authors:  Ram Weiss; James Dziura; Tania S Burgert; William V Tamborlane; Sara E Taksali; Catherine W Yeckel; Karin Allen; Melinda Lopes; Mary Savoye; John Morrison; Robert S Sherwin; Sonia Caprio
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study.

Authors:  O T Raitakari; K V Porkka; L Räsänen; T Rönnemaa; J S Viikari
Journal:  J Clin Epidemiol       Date:  1994-10       Impact factor: 6.437

View more
  9 in total

1.  Pediatric obesity. An introduction.

Authors:  Jack A Yanovski
Journal:  Appetite       Date:  2015-03-30       Impact factor: 3.868

2.  Abdominal obesity: what does it mean in an adolescent?

Authors:  Jennifer M O'Donnell; Catherine M Gordon
Journal:  J Clin Densitom       Date:  2014-11-13       Impact factor: 2.617

3.  Metabolic risk assessment in children and adolescents using the tri-ponderal mass index.

Authors:  Young-Jun Seo; Young Suk Shim; Hae Sang Lee; Jin Soon Hwang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

4.  Multilevel Understanding of the Impact of Individual- and School-Level Determinants on Lipid Profiles in Adolescents: The Cross-Level Interaction of Food Environment and Body Mass Index.

Authors:  Wei-Ting Lin; Yu-Ting Chin; Pei-Wen Wu; Sharon Tsai; Meng-Hsueh Chen; Chiao-I Chang; Yu-Cheng Yang; Chun-Ying Lee; David W Seal; Chien-Hung Lee
Journal:  Nutrients       Date:  2022-05-15       Impact factor: 6.706

5.  Metabolic Syndrome and Its Components in Young Adults Conceived by ICSI.

Authors:  F Belva; M Bonduelle; S Provyn; R C Painter; H Tournaye; M Roelants; J De Schepper
Journal:  Int J Endocrinol       Date:  2018-05-03       Impact factor: 3.257

6.  Association of Iron Storage Markers with Metabolic Syndrome and Its Components in Chinese Rural 6-12 Years Old Children: The 2010-2012 China National Nutrition and Health Survey.

Authors:  Huidi Zhang; Lijuan Wang; Siran Li; Xiaobing Liu; Yuqian Li; Yuna He; Qingqing Man; Lichen Yang
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

7.  Stability and Transformation of Metabolic Syndrome in Adolescents: A Prospective Assessment in Relation to the Change of Cardiometabolic Risk Factors.

Authors:  Pei-Wen Wu; Yi-Wen Lai; Yu-Ting Chin; Sharon Tsai; Tun-Min Yang; Wei-Ting Lin; Chun-Ying Lee; Wei-Chung Tsai; Hsiao-Ling Huang; David W Seal; Tsai-Hui Duh; Chien-Hung Lee
Journal:  Nutrients       Date:  2022-02-10       Impact factor: 5.717

8.  Characteristic-Grouped Adiposity Indicators for Identifying Metabolic Syndrome in Adolescents: Develop and Valid Risk Screening Tools Using Dual Population.

Authors:  Yu-Ting Chin; Wei-Ting Lin; Pei-Wen Wu; Sharon Tsai; Chun-Ying Lee; David W Seal; Ted Chen; Hsiao-Ling Huang; Chien-Hung Lee
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

Review 9.  The prevalence of pediatric metabolic syndrome-a critical look on the discrepancies between definitions and its clinical importance.

Authors:  Carolin Reisinger; Benedicta N Nkeh-Chungag; Per Morten Fredriksen; Nandu Goswami
Journal:  Int J Obes (Lond)       Date:  2020-11-18       Impact factor: 5.095

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.